Cell Biology Quiz: Translation
20 questions · exam conditions
0:00
TranslationQuestion 1 of 20

In prokaryotic translation termination, RF1 recognizes UAA and UAG stop codons, while RF2 recognizes UAA and UGA. If a mutation eliminates RF1 function but RF2 remains active, what pattern of translation termination would be observed?

All translation would terminate normally because RF2 can compensate for RF1 at all stop codons
Translation would terminate efficiently at UAA and UGA codons but exhibit read-through at UAG codons
Only UAA codons would support normal termination while both UAG and UGA would show read-through
Termination efficiency would decrease equally at all three stop codons due to reduced release factor concentration
RF2 would evolve altered specificity to recognize UAG codons within several generations of bacterial growth
← Back to quizzes

Cell Biology Quiz

Cell Biology Quiz: Translation

Practice Translation in Cell Biology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Translation, giving you a quick way to practice the rules, question types, and explanations that matter most for Cell Biology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

In prokaryotic translation termination, RF1 recognizes UAA and UAG stop codons, while RF2 recognizes UAA and UGA. If a mutation eliminates RF1 function but RF2 remains active, what pattern of translation termination would be observed?

  1. All translation would terminate normally because RF2 can compensate for RF1 at all stop codons
  2. Translation would terminate efficiently at UAA and UGA codons but exhibit read-through at UAG codons (correct answer)
  3. Only UAA codons would support normal termination while both UAG and UGA would show read-through
  4. Termination efficiency would decrease equally at all three stop codons due to reduced release factor concentration
  5. RF2 would evolve altered specificity to recognize UAG codons within several generations of bacterial growth
Explanation: When you encounter questions about prokaryotic translation termination, focus on the specific recognition patterns of release factors and what happens when one is eliminated. In prokaryotes, translation termination requires release factors that recognize specific stop codons. RF1 recognizes UAA and UAG, while RF2 recognizes UAA and UGA. Notice that UAA is recognized by both factors, creating redundancy for this particular stop codon. If RF1 function is eliminated while RF2 remains active, you can predict the outcome by mapping which codons still have functional recognition. UAA codons will terminate efficiently because RF2 still recognizes them. UGA codons will also terminate efficiently since RF2 is their primary recognition factor. However, UAG codons lose their only recognition factor (RF1), leading to read-through where ribosomes continue translating past the stop codon. Answer A is incorrect because RF2 cannot recognize UAG codons—there's no compensation mechanism for this specificity. Answer C misses that RF2 still efficiently recognizes UGA codons; it's not dependent on RF1 for UGA recognition. Answer D incorrectly suggests equal effects across all stop codons, ignoring the distinct recognition specificities of each release factor. The key insight is that elimination of one release factor only affects the stop codons it specifically recognizes, except where there's redundancy (like both factors recognizing UAA). Study tip: Memorize the recognition patterns (RF1: UAA/UAG, RF2: UAA/UGA) and remember that UAA has redundant recognition while UAG and UGA each depend on their specific factor.

Question 2

During prokaryotic translation initiation, IF2 binds to fMet-tRNA and helps position it in the P site of the small ribosomal subunit. If IF2's GTPase activity is eliminated by mutation but its tRNA-binding function remains intact, what would be the expected consequence?

  1. Initiation would fail completely because fMet-tRNA could not bind to the ribosome in the absence of GTP hydrolysis
  2. The 30S initiation complex would form normally but the 50S subunit could not join to complete ribosome assembly
  3. Translation would initiate normally but the first peptide bond formation would be significantly delayed or impaired
  4. Multiple IF2 molecules would accumulate on each ribosome, blocking subsequent rounds of translation initiation
  5. The ribosome would form but IF2 would not dissociate, interfering with the transition to elongation phase (correct answer)
Explanation: When you encounter questions about translation initiation factors, focus on the sequential steps and the specific role of GTP hydrolysis in factor release and complex transitions. IF2 serves a dual function during prokaryotic translation initiation: it binds fMet-tRNA and escorts it to the P site, then undergoes GTP hydrolysis to release itself after the 70S ribosome assembles. If IF2 retains its tRNA-binding ability but loses GTPase activity, it would successfully deliver fMet-tRNA and allow 70S assembly to proceed normally. However, without GTP hydrolysis, IF2 cannot release from the ribosome after completing its job. This creates a critical bottleneck: IF2 remains stuck on the ribosome, occupying space and likely interfering with the ribosome's ability to advance to elongation. The first peptide bond formation requires precise positioning of both the P-site fMet-tRNA and the incoming aminoacyl-tRNA in the A site, along with proper conformational changes in the ribosome. The persistent presence of IF2 would sterically hinder these processes. Answer A is wrong because fMet-tRNA binding doesn't require GTP hydrolysis—only IF2's eventual release does. Answer B incorrectly suggests 50S joining is affected, but this step precedes the GTP hydrolysis requirement. Answer D misunderstands the mechanism—one IF2 per initiation event would be trapped, not multiple molecules accumulating. Remember that GTPase activities of translation factors typically drive conformational changes and factor release rather than initial binding events. When you see questions about factor mutations, ask yourself: "At what step would this protein normally release, and what happens if it can't?"

Question 3

During translation initiation in prokaryotes, the ribosome must position the start codon correctly in the P site. If a mutation causes the Shine-Dalgarno sequence to be deleted from an mRNA, what is the most likely consequence for the resulting polypeptide?

  1. The polypeptide will be synthesized normally but will lack the first methionine residue
  2. Translation will initiate at an incorrect position, producing a polypeptide with an altered amino acid sequence (correct answer)
  3. The ribosome will bind normally but elongation will proceed at a significantly reduced rate
  4. Translation will terminate prematurely due to improper ribosome positioning on the mRNA
  5. The polypeptide will be synthesized with normal sequence but at reduced efficiency levels
Explanation: When you encounter questions about prokaryotic translation initiation, focus on the critical role of the Shine-Dalgarno (SD) sequence in proper ribosome positioning. The SD sequence is a purine-rich region located about 8 base pairs upstream of the start codon that base-pairs with complementary sequences in the 16S rRNA of the small ribosomal subunit. This interaction is essential for correctly positioning the start codon in the P site of the ribosome. Without the SD sequence, the ribosome loses its primary mechanism for recognizing the correct translation start site. The ribosome will still attempt to initiate translation, but it will likely bind at an incorrect position on the mRNA. This misalignment means translation will begin at the wrong nucleotide sequence, producing a polypeptide with a completely altered amino acid sequence from what the gene normally encodes. Choice A is incorrect because the problem isn't simply missing the first methionine—the entire reading frame is disrupted. Choice C misses the point entirely; the ribosome binding and positioning is the issue, not elongation rate once translation begins. Choice D is wrong because improper positioning doesn't typically cause premature termination—rather, it leads to translation of an incorrect sequence until a stop codon is eventually encountered. Remember that the SD sequence is prokaryote-specific and absolutely essential for proper translation initiation. When you see questions about mutations affecting ribosome binding sites, always consider how they impact the reading frame and overall protein sequence, not just individual amino acids.

Question 4

A researcher observes that when puromycin is added to a translation system, incomplete polypeptides are released from ribosomes. Based on puromycin's mechanism of action, at which stage of translation does this antibiotic primarily interfere?

  1. Initiation, by preventing the formation of the ribosome-mRNA complex at the start codon
  2. Elongation, by blocking the translocation step that moves peptidyl-tRNA from A site to P site
  3. Elongation, by causing premature release of the growing polypeptide chain from the ribosome (correct answer)
  4. Termination, by preventing release factors from recognizing stop codons in the A site
  5. Termination, by blocking the hydrolysis reaction that releases completed polypeptides from tRNA
Explanation: When you encounter questions about translation inhibitors, focus on understanding how each antibiotic disrupts the normal ribosomal machinery at specific steps. Puromycin works by mimicking aminoacyl-tRNA and entering the ribosome's A site during elongation. However, instead of participating in normal peptide bond formation, puromycin causes the growing polypeptide chain to be released prematurely from the ribosome. This happens because puromycin can accept the growing peptide chain from the peptidyl-tRNA in the P site, but then cannot properly continue the elongation cycle. The result is incomplete polypeptides being released before translation should naturally terminate. Looking at the wrong answers: A is incorrect because puromycin doesn't prevent ribosome-mRNA complex formation at initiation—it acts during active translation. B misidentifies the mechanism; puromycin doesn't block translocation between ribosomal sites, but rather disrupts the peptide bond formation process itself. D is wrong because puromycin doesn't interfere with normal termination signals—instead, it creates an artificial termination by causing premature release. The key observation in the question—"incomplete polypeptides are released"—directly points to premature chain termination during elongation, which is puromycin's signature effect. Remember that translation inhibitors have distinct mechanisms: some block initiation, others prevent translocation, and some (like puromycin) cause premature termination. Always connect the observed phenotype (incomplete proteins) with the specific molecular mechanism to identify where in translation the interference occurs.

Question 5

In eukaryotic translation initiation, the small ribosomal subunit binds to the 5' cap and scans for the start codon. If a mutation introduces a strong secondary structure in the 5' untranslated region that blocks scanning, which outcome is most likely?

  1. The ribosome will bind normally to the cap but initiate translation at the first available AUG downstream
  2. Translation efficiency will decrease significantly because the ribosome cannot reach the proper start codon (correct answer)
  3. The ribosome will bypass the secondary structure and initiate translation at internal ribosome entry sites
  4. Cap-independent translation will compensate by allowing direct ribosome binding to the start codon region
  5. The secondary structure will be resolved by RNA helicases during the normal scanning process
Explanation: When you encounter questions about eukaryotic translation initiation, focus on the sequential steps: cap binding, ribosome scanning, and start codon recognition. This process is highly dependent on the ribosome's ability to physically move along the mRNA. In normal translation initiation, the small ribosomal subunit binds to the 5' cap structure and then scans linearly along the mRNA until it encounters the start codon (usually AUG). This scanning process requires the ribosome to move smoothly through the 5' untranslated region (UTR). When a strong secondary structure like a hairpin loop forms in this region, it creates a physical barrier that blocks ribosomal movement, preventing the scanning complex from reaching the start codon. This dramatically reduces translation efficiency, making option B correct. Option A is wrong because even though the ribosome binds to the cap normally, the secondary structure prevents it from scanning to reach any downstream AUG codons. Option C incorrectly suggests that internal ribosome entry sites (IRES) would automatically compensate—while some mRNAs do have IRES elements, they're specialized sequences that aren't universally present and wouldn't suddenly appear due to a mutation creating secondary structure. Option D misrepresents how cap-independent translation works; it doesn't simply allow direct binding to start codons and typically involves IRES-mediated mechanisms. Remember that ribosomal scanning is a physical process—any structural impediment in the 5' UTR will likely block translation initiation. When studying translation, always consider the mechanical aspects of ribosome movement along mRNA.

Question 6

A nonsense mutation creates a premature stop codon in the middle of a coding sequence. During translation of this mutant mRNA, what will happen when the ribosome encounters this premature stop codon?

  1. The ribosome will pause briefly but continue translation by reading through the stop codon
  2. Release factors will bind and cause termination, producing a truncated polypeptide fragment (correct answer)
  3. The ribosome will dissociate immediately without releasing any polypeptide product from the tRNA
  4. Translation will switch reading frames to avoid the stop codon and continue with normal elongation
  5. The stop codon will be recognized as a sense codon due to its unusual position within the gene
Explanation: When you encounter questions about nonsense mutations and translation termination, focus on understanding how ribosomes recognize and respond to stop codons during protein synthesis. A nonsense mutation introduces a premature stop codon (UAG, UAA, or UGA) where an amino acid codon should be. When the ribosome reaches this stop codon during translation, it triggers the normal termination machinery. Release factors (eRF1 in eukaryotes, RF1 or RF2 in prokaryotes) recognize the stop codon in the A site and bind to the ribosome. These factors activate the peptidyl transferase center to hydrolyze the bond between the growing polypeptide and the tRNA in the P site, releasing a shortened, incomplete protein fragment. This is exactly what answer B describes. Answer A is incorrect because ribosomes cannot "read through" stop codons under normal conditions - they lack tRNAs with anticodons complementary to stop codons. Answer C misunderstands the termination process; the polypeptide is always released from the tRNA during proper termination, even when premature. Answer D describes frameshifting, which is a separate phenomenon that can occur due to ribosome slippage at repetitive sequences, not a response to encountering stop codons. Remember that nonsense mutations create functional stop codons, so ribosomes treat them exactly like normal stop codons - they cannot distinguish between intended and premature termination signals. The key concept is that translation termination always produces a released polypeptide product, regardless of whether termination occurs at the correct location.

Question 7

During translation elongation, EF-Tu delivers aminoacyl-tRNA to the A site of the ribosome. If a mutation reduces EF-Tu's GTPase activity but does not affect its tRNA-binding capability, what would be the primary effect on translation?

  1. Aminoacyl-tRNAs would bind normally to the A site and translation would proceed at normal rates
  2. The rate of aminoacyl-tRNA delivery would increase due to enhanced EF-Tu stability in the GTP-bound state
  3. Translation elongation would slow significantly because EF-Tu would remain bound to the ribosome longer than normal (correct answer)
  4. Peptide bond formation would be impaired because EF-Tu would interfere with peptidyl transferase activity
  5. The fidelity of translation would decrease because proofreading mechanisms would be bypassed completely
Explanation: When you encounter questions about translation factors and GTP hydrolysis, focus on the conformational changes that drive the translation cycle. EF-Tu operates through a classic GTP-binding protein mechanism where GTP hydrolysis triggers conformational changes essential for proper function. EF-Tu normally delivers aminoacyl-tRNA to the ribosomal A site in its GTP-bound state. After correct codon-anticodon pairing is verified, EF-Tu hydrolyzes GTP to GDP, causing a conformational change that releases the aminoacyl-tRNA and allows EF-Tu to dissociate from the ribosome. If GTPase activity is reduced, EF-Tu remains "stuck" in its GTP-bound conformation, staying attached to both the tRNA and ribosome much longer than normal. This creates a bottleneck that significantly slows translation elongation, making C correct. Option A is wrong because while initial binding might occur normally, the overall translation rate would decrease due to EF-Tu's prolonged ribosome occupancy. Option B incorrectly suggests faster delivery, but the problem isn't delivery speed—it's EF-Tu's inability to release efficiently after delivery. Option D misidentifies the problem; peptide bond formation itself wouldn't be directly impaired since that occurs at the peptidyl transferase center, but the entire elongation cycle would be disrupted by EF-Tu's persistent binding. Remember that GTPase activity in translation factors isn't just about energy—it's primarily about timing and conformational switches. When you see questions about impaired GTPase activity, think about proteins getting "stuck" in one conformational state.

Question 8

In prokaryotic translation, the ribosome must coordinate the binding of aminoacyl-tRNA to the A site with the movement of peptidyl-tRNA from the P site to the E site. What ensures that these events occur in the proper sequence during elongation?

  1. The binding affinity of aminoacyl-tRNA is always higher than that of peptidyl-tRNA for ribosomal sites
  2. Translocation only occurs after successful peptide bond formation and conformational changes in the ribosome (correct answer)
  3. EF-G binding prevents new aminoacyl-tRNA from entering until translocation has been completed fully
  4. The E site must be empty before the A site can accommodate any incoming aminoacyl-tRNA molecules
  5. Release factors monitor each step and prevent progression until the previous step has been verified
Explanation: Translation elongation is a highly coordinated process where timing and sequence are critical for accurate protein synthesis. The ribosome must ensure that each step completes properly before the next begins, preventing errors that could produce defective proteins. The correct mechanism ensuring proper sequencing is that translocation only occurs after successful peptide bond formation and conformational changes in the ribosome (B). Here's how it works: when aminoacyl-tRNA enters the A site, peptide bond formation occurs between the growing peptide chain and the new amino acid. This triggers conformational changes in the ribosome that signal readiness for translocation. Only then does EF-G promote the movement of tRNAs from A→P→E sites. These structural changes act as checkpoints, ensuring each step is complete before proceeding. Let's examine why the other options are incorrect. Choice A is wrong because binding affinities don't determine the sequence of events—conformational changes do. The ribosome doesn't rely on simple competitive binding. Choice C reverses the actual mechanism: EF-G binding facilitates translocation rather than preventing new aminoacyl-tRNA entry, and new tRNA can bind after translocation completes. Choice D describes a constraint that doesn't exist—the A site can accommodate aminoacyl-tRNA regardless of E site occupancy. Remember that ribosomal fidelity depends on conformational proofreading mechanisms. When studying translation, focus on how structural changes in the ribosome serve as quality control checkpoints that coordinate the timing of each elongation step.

Question 9

A researcher studying translation termination finds that when eRF1 is depleted in eukaryotic cells, ribosomes accumulate at stop codons but do not release polypeptides. However, when both eRF1 and eRF3 are depleted, fewer ribosomes accumulate at stop codons. What does this suggest about eRF3's role?

  1. eRF3 is required for stop codon recognition and eRF1 binding to the ribosome at termination sites (correct answer)
  2. eRF3 functions independently of eRF1 to catalyze polypeptide release from peptidyl-tRNA during normal termination
  3. eRF3 enhances the binding stability of eRF1 at stop codons but is not essential for termination
  4. eRF3 prevents ribosome read-through at stop codons by blocking the A site when eRF1 is absent
  5. eRF3 regulates the recycling of eRF1 between multiple termination events on different ribosomes
Explanation: When analyzing translation termination experiments, you need to understand how the two eukaryotic release factors work together. The key insight here comes from comparing what happens when you deplete one factor versus both factors. The correct answer is A because the experimental results reveal eRF3's essential role in the termination process. When only eRF1 is depleted, ribosomes pile up at stop codons because they can recognize the stop signal (thanks to eRF3) and eRF1 attempts to bind, but without functional eRF1, termination cannot complete. However, when both eRF1 and eRF3 are depleted, fewer ribosomes accumulate because eRF3 is no longer available to recognize stop codons and recruit eRF1 in the first place - so ribosomes more often read through the stop codons instead of pausing. Answer B is wrong because eRF3 doesn't function independently of eRF1 - the experiment shows they work together, and eRF1 is the factor that actually catalyzes peptide release. Answer C incorrectly suggests eRF3 is non-essential, but the reduced accumulation when both factors are depleted proves eRF3 has a crucial role in initial recognition and recruitment. Answer D misinterprets the mechanism - eRF3 doesn't block the A site when eRF1 is absent; instead, it's responsible for bringing eRF1 to the ribosome. Remember: In translation termination questions, always consider how the experimental manipulation affects each step of the process - recognition, binding, and catalysis - to understand factor interactions.

Question 10

A mutation in a tRNA molecule alters its structure such that it can still be aminoacylated correctly but cannot bind to EF-Tu. How would this mutation most directly affect the translation process?

  1. The amino acid would be incorporated into proteins through direct binding of aminoacyl-tRNA to the ribosome
  2. Translation of codons requiring this tRNA would slow dramatically due to reduced delivery efficiency to ribosomes (correct answer)
  3. The aminoacyl-tRNA would bind to the ribosome but would be rejected during the proofreading step
  4. Other tRNAs with similar anticodons would compensate by increasing their affinity for the affected codons
  5. The tRNA would function normally because EF-Tu binding is only required for initial ribosome recruitment
Explanation: When you encounter questions about tRNA mutations and translation factors, focus on the step-by-step process of how aminoacyl-tRNAs reach the ribosome. EF-Tu (elongation factor Tu) is essential for delivering aminoacyl-tRNA to the ribosomal A-site - without it, the aminoacyl-tRNA cannot efficiently reach its destination. If a tRNA can still be aminoacylated correctly but cannot bind EF-Tu, the charged tRNA exists in the cell but has no reliable transport mechanism to the ribosome. This creates a severe bottleneck in translation. While the tRNA might occasionally reach the ribosome through random diffusion, this process would be extremely inefficient compared to the normal EF-Tu-mediated delivery system. Therefore, translation of codons requiring this particular tRNA would slow dramatically due to reduced delivery efficiency (B). Looking at the incorrect options: (A) suggests direct binding compensates for the defect, but aminoacyl-tRNAs have very low affinity for ribosomes without EF-Tu - this wouldn't maintain normal translation rates. (C) assumes the tRNA reaches the ribosome normally but fails proofreading, but the primary problem is delivery, not accuracy. (D) proposes other tRNAs compensate by changing their codon specificity, but tRNA anticodon recognition is determined by base-pairing rules and wouldn't spontaneously adapt. Remember that translation elongation depends on a precise delivery system. When you see questions about EF-Tu mutations, always consider the transport function first - if aminoacyl-tRNAs can't reach the ribosome efficiently, translation speed suffers regardless of other factors.

Question 11

In eukaryotic translation, the ribosome scanning model explains how the start codon is located. If a cellular stress condition reduces the availability of eIF4E (cap-binding protein), which aspect of translation initiation would be most directly affected?

  1. The small ribosomal subunit would still bind to mRNA but scanning efficiency would decrease significantly
  2. Start codon recognition would be impaired even when ribosomes successfully bind to the mRNA molecule
  3. The initial binding of the 40S ribosomal subunit to the 5' end of mRNA would be severely reduced (correct answer)
  4. Large ribosomal subunit joining would be prevented despite normal small subunit binding and scanning
  5. Translation would shift to cap-independent mechanisms without affecting overall protein synthesis rates significantly
Explanation: When you encounter questions about translation initiation in eukaryotes, focus on the sequential steps of ribosome assembly and the specific roles of initiation factors. eIF4E is the cap-binding protein that recognizes and binds to the 5' methylguanosine cap structure of eukaryotic mRNAs. This binding is absolutely essential for the ribosome scanning model to begin. The process works like this: eIF4E binds the 5' cap, then recruits other initiation factors and ultimately the 40S ribosomal subunit to form the pre-initiation complex at the 5' end of the mRNA. Only after this initial binding can the ribosome scan downstream to locate the start codon. Without sufficient eIF4E, ribosomes simply cannot recognize and bind to the capped 5' end of mRNA molecules, making answer C correct. The initial binding event is completely dependent on this cap recognition. A is wrong because if eIF4E is unavailable, ribosomes won't bind to mRNA at all—there's no scanning to be inefficient. B incorrectly suggests that start codon recognition is the primary problem, but the issue occurs much earlier in the process before any scanning begins. D is incorrect because large subunit joining happens after successful small subunit binding and start codon recognition—but with reduced eIF4E, you never get past the initial binding step. Remember that eukaryotic translation initiation is highly dependent on the 5' cap structure. When you see questions about cap-binding proteins or eIF4E, think about the very first step of ribosome recruitment, not the later scanning or assembly events.

Question 12

During eukaryotic translation initiation, the 48S pre-initiation complex scans the 5' UTR for the start codon. If a mutation creates an upstream AUG codon in optimal Kozak context before the normal start codon, what is the most likely outcome?

  1. Both AUG codons will be used equally, producing two different protein isoforms in equal amounts
  2. The ribosome will preferentially initiate at the upstream AUG, reducing translation from the normal start site (correct answer)
  3. The upstream AUG will be ignored because it is not in the proper position relative to the 5' cap
  4. Translation efficiency will increase because multiple start sites provide redundancy for protein synthesis
  5. The ribosome will scan past both AUG codons and initiate at the next available methionine codon
Explanation: When you encounter questions about eukaryotic translation initiation, focus on the scanning mechanism and how ribosomes select start codons. The 40S ribosomal subunit binds near the 5' cap and scans linearly toward the 3' end, searching for the first AUG codon in favorable context. The ribosome follows a "first AUG wins" rule during scanning. When it encounters an upstream AUG in optimal Kozak context (featuring purines at positions -3 and +4 relative to the AUG), the ribosome will preferentially initiate translation there. This upstream initiation reduces the number of ribosomes that continue scanning to reach the normal start site, decreasing translation from the original AUG. The upstream AUG essentially "captures" scanning ribosomes before they can reach the intended start codon. Answer A is incorrect because ribosomes don't randomly choose between start codons—they follow the scanning rule and initiate at the first suitable AUG they encounter. Answer C misunderstands the scanning mechanism; position relative to the 5' cap doesn't matter as long as the AUG is downstream and in good context. Answer D incorrectly assumes multiple start sites increase efficiency, when upstream AUGs actually compete with and reduce translation from downstream sites. Remember that ribosomal scanning is unidirectional and follows a "first come, first served" principle. Strong upstream AUGs act as translation roadblocks, reducing protein production from the intended start site—a common mechanism for regulating gene expression through 5' UTR mutations.

Question 13

A mutant tRNA has an altered acceptor stem that prevents proper aminoacylation, but its anticodon and overall structure remain normal. During translation, what would happen when the ribosome encounters a codon that requires this tRNA?

  1. The uncharged tRNA would bind to the A site and cause translation to pause until aminoacylation occurs
  2. EF-Tu would still deliver the uncharged tRNA to the ribosome, but peptide bond formation would fail
  3. The ribosome would skip this codon and continue translation with the next codon in the sequence
  4. Translation would slow at this position because only charged tRNAs can form ternary complexes with EF-Tu (correct answer)
  5. Other tRNAs would misread the codon to compensate for the unavailable aminoacyl-tRNA species
Explanation: When you encounter questions about tRNA function in translation, focus on the critical relationship between aminoacylation (charging) and the formation of ternary complexes that deliver amino acids to ribosomes. The key insight here is that EF-Tu (elongation factor Tu) has a strong preference for aminoacyl-tRNA over uncharged tRNA. EF-Tu forms ternary complexes (EF-Tu•GTP•aminoacyl-tRNA) that efficiently deliver charged tRNAs to the ribosomal A site. Since your mutant tRNA cannot be properly charged due to its defective acceptor stem, it rarely forms these ternary complexes, making delivery to the ribosome much less efficient. This creates a bottleneck at codons requiring this tRNA, slowing translation as the ribosome waits for the rare delivery events. Answer D correctly captures this mechanism. Answer A is incorrect because uncharged tRNAs don't readily bind the A site—they need EF-Tu delivery, which is impaired. Answer B misses the point entirely; the problem isn't failed peptide bond formation but rather failed delivery to begin with. The uncharged tRNA would rarely reach the A site due to poor ternary complex formation. Answer C suggests codon skipping, but ribosomes don't skip codons—they translate sequentially and would pause at this position instead. Remember this principle: charged tRNAs are preferentially selected by EF-Tu. When you see questions about aminoacylation defects, think about the upstream consequences for ternary complex formation and delivery efficiency, not just the downstream effects on peptide bond chemistry.

Question 14

In prokaryotic translation, the ribosome recycling factor (RRF) works with EF-G to disassemble ribosomes after termination. If RRF function is impaired, what would be the most significant consequence for bacterial protein synthesis?

  1. Translation termination would fail, causing ribosomes to read through stop codons continuously
  2. Completed ribosomes would remain bound to mRNA, reducing the pool of free ribosomal subunits available for new initiation (correct answer)
  3. The fidelity of translation would decrease because ribosomes would not properly reset between translation cycles
  4. mRNA stability would be compromised because ribosomes would not protect transcripts from degradation
  5. Translation elongation rates would slow because ribosome recycling is coupled to the elongation machinery
Explanation: When you encounter questions about ribosome recycling factor (RRF), focus on its specific role in the ribosome cycle rather than translation accuracy or termination itself. RRF doesn't participate in the actual termination process—that's handled by release factors that recognize stop codons. Instead, RRF functions after termination is complete. Here's what actually happens: After a ribosome finishes translating an mRNA and releases the completed protein, it remains assembled on the mRNA as an 70S complex. RRF, working with elongation factor EF-G, actively disassembles this post-termination ribosome into its 30S and 50S subunits, which can then be recycled for new rounds of translation initiation. If RRF function is impaired, these completed ribosomes stay stuck on mRNAs as intact 70S complexes. This creates a bottleneck because only free 30S subunits can initiate new translation by binding to ribosome binding sites. With fewer subunits available in the free pool, the overall rate of translation initiation drops significantly, making answer B correct. Answer A is wrong because translation termination still occurs normally through release factors—RRF acts after termination. Answer C misunderstands RRF's role; it doesn't affect translation fidelity but rather ribosome availability. Answer D incorrectly suggests RRF affects mRNA stability, when its function is purely mechanical ribosome disassembly. Remember: RRF questions test ribosome recycling, not termination accuracy. Think "traffic flow"—if cars (ribosomes) don't clear the exit ramp (mRNA), new cars can't enter the highway (start translation).

Question 15

In eukaryotic cells, some mRNAs have internal ribosome entry sites (IRES) that allow cap-independent translation initiation. During cellular stress when cap-dependent translation is inhibited, what advantage would IRES-containing mRNAs have?

  1. They would be translated more efficiently because ribosomes would have higher affinity for IRES sequences than caps
  2. They would continue to be translated while most other mRNAs experience reduced translation due to cap-dependent inhibition (correct answer)
  3. They would be protected from stress-induced mRNA degradation by maintaining continuous ribosome association
  4. They would recruit additional translation factors that are not required for normal cap-dependent translation initiation
  5. They would undergo enhanced proofreading during elongation, producing more accurate proteins during stress conditions
Explanation: Translation initiation in eukaryotes typically requires recognition of the 5' cap structure, but some mRNAs contain internal ribosome entry sites (IRES) that provide an alternative pathway. Understanding this dual system is crucial when analyzing cellular responses to stress. During cellular stress, cap-dependent translation is often inhibited through various mechanisms, including sequestration of cap-binding proteins and eIF4F complex disruption. However, IRES-containing mRNAs can bypass this inhibition entirely because they don't rely on cap recognition for ribosome recruitment. Instead, ribosomes bind directly to internal sequences within the mRNA, allowing translation to continue even when cap-dependent mechanisms are shut down. This makes answer B correct—these mRNAs maintain translation while most others experience reduced protein synthesis. Answer A incorrectly suggests ribosomes have higher affinity for IRES than caps. Ribosome affinity isn't the determining factor; rather, it's about which initiation pathway remains functional during stress. Answer C misrepresents the protective mechanism. While continuous ribosome association might provide some protection from degradation, the primary advantage is continued translation, not mRNA stability. Answer D is incorrect because IRES-mediated translation actually uses many of the same translation factors as cap-dependent translation, just through a different recruitment mechanism. When studying translation regulation, remember that cells often maintain alternative pathways for essential processes. IRES sequences are particularly important for translating stress-response proteins and survival factors when normal translation is compromised—a classic example of cellular redundancy ensuring critical functions continue during adverse conditions.

Question 16

A mutation affects the GTPase activity of eEF2 (eukaryotic elongation factor 2) such that GTP hydrolysis is severely reduced but GTP binding remains normal. What would be the primary effect on translation elongation?

  1. Translocation would fail completely because eEF2 could not bind to the ribosome in the GTP-bound state
  2. Peptidyl-tRNA would move normally from A to P site, but deacylated tRNA would not exit the E site
  3. The rate of translocation would decrease dramatically because eEF2 would remain bound to ribosomes for extended periods (correct answer)
  4. Translation fidelity would improve because eEF2 would have more time to ensure proper tRNA positioning
  5. Ribosomes would begin translating in multiple reading frames due to impaired coordination of the translocation process
Explanation: When you encounter questions about elongation factors and GTPase activity, focus on the mechanism of protein synthesis and how GTP hydrolysis drives conformational changes that allow factor recycling. eEF2 facilitates ribosomal translocation by binding to the ribosome in its GTP-bound state, promoting movement of peptidyl-tRNA from the A site to P site and deacylated tRNA from P to E site. Crucially, GTP hydrolysis to GDP causes a conformational change in eEF2 that reduces its affinity for the ribosome, allowing it to dissociate and making the ribosome available for the next round of elongation. If GTP hydrolysis is severely impaired while GTP binding remains normal, eEF2 would bind normally but become "stuck" on ribosomes because it cannot undergo the conformational change needed for release. This creates a bottleneck where ribosomes are occupied by non-functional eEF2, dramatically slowing translocation rates. Option A is incorrect because eEF2 binds to ribosomes specifically in the GTP-bound state - this is its active form. Option B misunderstands the defect; the mutation affects eEF2 dissociation, not the translocation mechanism itself, so both tRNA movements would be impaired equally. Option D incorrectly suggests that prolonged eEF2 binding improves fidelity, but translation accuracy depends on aminoacyl-tRNA selection at the A site, not elongation factor residence time. Remember: GTPase activity in translation factors isn't just about energy - it's primarily a timing mechanism that controls factor dissociation and allows the translation machinery to reset for the next cycle.

Question 17

During translation elongation, proofreading occurs to ensure accuracy. If a near-cognate aminoacyl-tRNA (one that imperfectly matches the codon) enters the A site, at what point in the elongation cycle would it most likely be rejected?

  1. Immediately upon initial binding to the A/T site before any conformational changes occur in the ribosome
  2. After EF-Tu GTP hydrolysis but before the aminoacyl-tRNA fully accommodates into the A/A site (correct answer)
  3. During peptide bond formation when the imperfect match prevents proper peptidyl transferase activity
  4. After peptide bond formation but before translocation moves the peptidyl-tRNA to the P site
  5. During translocation when the near-cognate tRNA cannot properly move from A site to P site
Explanation: Translation elongation involves sophisticated proofreading mechanisms that occur in multiple stages to ensure accuracy. When you encounter questions about translation fidelity, focus on the two-step selection process that catches errors at different checkpoints. The ribosome uses a two-stage proofreading system. Initially, all aminoacyl-tRNAs (including near-cognate ones) can bind to the A/T site through their EF-Tu•GTP complex. The first proofreading step occurs after EF-Tu hydrolyzes GTP but before the aminoacyl-tRNA moves into the final A/A position. During this critical window, the ribosome samples the codon-anticodon interaction. If the match is imperfect, the near-cognate aminoacyl-tRNA is rejected and dissociates from the ribosome before it can fully accommodate into the A/A site and participate in peptide bond formation. Option A is incorrect because initial binding to the A/T site is relatively permissive—both correct and near-cognate tRNAs can bind initially. Option C misrepresents the process; peptidyl transferase activity itself doesn't serve as the primary proofreading mechanism, and by this point, the incorrect tRNA would have already passed the quality control checkpoints. Option D is wrong because proofreading for codon-anticodon matching occurs before peptide bond formation, not after. Remember that ribosomal proofreading is kinetic—it relies on the different rates of accommodation and dissociation between correct matches and near-cognate pairs. This timing-based mechanism explains why rejection occurs in the intermediate step after GTP hydrolysis but before full accommodation.

Question 18

During the elongation phase of translation, a peptide bond forms between the amino acid in the A site and the growing polypeptide in the P site. What would be the immediate consequence if the peptidyl transferase activity were inhibited at this step?

  1. The ribosome would dissociate from the mRNA and translation would terminate immediately
  2. Translocation would still occur, moving the unchanged peptidyl-tRNA from P site to E site
  3. The aminoacyl-tRNA would remain bound in the A site while the peptidyl-tRNA remains in the P site (correct answer)
  4. New aminoacyl-tRNAs would continue to bind to the A site, causing multiple tRNAs to accumulate
  5. The ribosome would skip to the next codon and attempt elongation with the following aminoacyl-tRNA
Explanation: Questions about protein synthesis mechanisms test your understanding of the sequential steps in translation and how disrupting one step affects the entire process. When you encounter translation questions, think about the precise order of events and what must happen before the next step can proceed. Peptidyl transferase is the ribosomal enzyme that catalyzes peptide bond formation between the amino acid attached to the A-site tRNA and the growing polypeptide chain attached to the P-site tRNA. If this activity were inhibited, the peptide bond simply wouldn't form. The aminoacyl-tRNA would remain bound in the A site with its amino acid still attached, while the peptidyl-tRNA would stay in the P site with the unchanged polypeptide chain. Translation would stall at this point because peptide bond formation must occur before translocation can proceed. Choice A is incorrect because ribosome dissociation and translation termination require specific termination signals, not just the absence of peptide bond formation. Choice B misunderstands the translation mechanism—translocation only occurs after successful peptide bond formation transfers the growing chain to the A-site tRNA. Without this transfer, there's no signal for the ribosome to move. Choice D incorrectly suggests that new tRNAs could bind while the A site is already occupied; the ribosome's A site can only accommodate one aminoacyl-tRNA at a time. Remember that translation elongation follows a strict sequence: aminoacyl-tRNA binding → peptide bond formation → translocation. Each step depends on successful completion of the previous step, so blocking any step halts the entire process at that point.

Question 19

A researcher finds that in a particular cell type, many ribosomes are stalled with peptidyl-tRNA in the A site instead of the normal P site. This suggests a defect in which specific step of the elongation cycle?

  1. Aminoacyl-tRNA binding to the A site is occurring but codon recognition is failing consistently
  2. Peptide bond formation is proceeding normally but the subsequent translocation step is impaired (correct answer)
  3. EF-Tu is binding correctly but GTP hydrolysis and release from the ribosome is blocked
  4. The proofreading mechanism is overactive, causing excessive rejection of correct aminoacyl-tRNAs
  5. Release factors are inappropriately binding to sense codons and interfering with normal elongation
Explanation: When you encounter questions about ribosome stalling during translation, focus on the three-site model of ribosome function and the specific steps of the elongation cycle. The ribosome has three key sites: A (aminoacyl), P (peptidyl), and E (exit), and tRNAs move sequentially through these sites during normal translation. The observation that peptidyl-tRNA is stuck in the A site instead of moving to the P site points directly to a translocation defect. During normal elongation, aminoacyl-tRNA first binds to the A site, then peptide bond formation occurs between the growing peptide chain (attached to tRNA in the P site) and the new amino acid (on tRNA in the A site). After the peptide bond forms, the peptidyl-tRNA should translocate from the A site to the P site, while the deacylated tRNA moves from P to E. If peptidyl-tRNA remains in the A site, this translocation step has failed, making choice B correct. Choice A is wrong because if codon recognition were failing, you wouldn't see peptidyl-tRNA formation in the A site at all. Choice C describes a problem during the initial binding phase, which occurs before translocation. Choice D suggests excessive proofreading, but this would prevent tRNA from reaching the peptidyl state in the first place. Remember that ribosome mechanics questions often test your understanding of the sequential nature of translation. Map out where specific molecules should be at each step—if they're in the wrong place, work backward to identify which step failed.

Question 20

A research team discovers a novel antibiotic that specifically prevents the release of deacylated tRNA from the E site of prokaryotic ribosomes. Based on this mechanism, what would be the primary effect on ongoing translation?

  1. Translation would continue normally because E site occupancy does not affect A site or P site function
  2. New rounds of translation initiation would be blocked while elongation of existing ribosomes continues
  3. Elongation would slow progressively as deacylated tRNAs accumulate and interfere with ribosome movement (correct answer)
  4. Translocation would be completely blocked because deacylated tRNA cannot move from E site to cytoplasm
  5. Ribosomes would dissociate prematurely due to improper coordination of the translation machinery
Explanation: Translation elongation requires precise coordination between ribosome sites, and understanding how the E site functions reveals why blocking tRNA release creates cascading problems throughout the process. When deacylated tRNA cannot exit the E site, it creates a traffic jam that progressively worsens. During normal elongation, the ribosome translocates along mRNA while tRNAs move from A→P→E sites before being released. If deacylated tRNAs accumulate in the E site, they physically obstruct the ribosome's movement and interfere with the incoming aminoacyl-tRNAs trying to enter the A site. This doesn't stop translation immediately, but creates increasingly sluggish elongation as more ribosomes become clogged with retained tRNAs. Option A incorrectly assumes the ribosome sites function independently. In reality, the sites are structurally and functionally interconnected—E site occupancy directly affects ribosome mobility and A site accessibility. Option B misunderstands the mechanism; this antibiotic targets elongation, not initiation factors, so new translation rounds could still begin normally. Option D overstates the effect by claiming complete blockade. While translocation becomes progressively impaired, it doesn't halt entirely at first—the effect builds gradually as deacylated tRNAs accumulate. The correct answer is C because the antibiotic creates a progressive slowdown rather than immediate cessation, as physical interference from accumulated tRNAs increasingly hampers ribosome function. Remember: ribosome sites work as an integrated system. When analyzing translation inhibitors, consider how blocking one step creates upstream and downstream effects rather than isolated problems.